stockrowProgyny, Inc.
PGNY Healthcare Healthcare Plans
Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +8.91%
- EPS
- +115.3%
- Free cash flow
- +2.72%
Quarter to September 2026, against a year earlier
Follow PGNY
Alert me
Progyny, Inc. (PGNY) Operating cash flow
Progyny, Inc.'s operating cash flow for fiscal 2025 was $210.2M, up 17.4% from $179.1M in fiscal 2024. Over the twelve months to 30 September 2026 it was $207.2M. Over the past ten years it has ranged from −$9.5M (fiscal 2017) to $210.2M (fiscal 2025) — the current reading is the highest in ten years. Progyny, Inc. ranks 9th of 12 Healthcare Plans companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $210.2M | 17.36% |
| FY2024 | $179.1M | (5.14%) |
| FY2023 | $188.8M | 134.86% |
| FY2022 | $80.4M | 208.77% |
| FY2021 | $26.0M | (28.08%) |
| FY2020 | $36.2M | — |
| FY2019 | −$1.5M | — |
| FY2018 | $2.3M | — |
| FY2017 | −$9.5M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $56.6M | 12.26% |
| Jun 2026 | $50.4M | 9.74% |
| Mar 2026 | $45.9M | (15.23%) |
| Dec 2025 | $54.2M | 6.97% |
| 31 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| CI Cigna Group compare | $9.4B |
| ELV Elevance Health, Inc. compare | $7.6B |
| CNC Centene Corporation compare | $4.7B |
| OSCR Oscar Health, Inc. compare | $4.2B |
| HUM Humana Inc. compare | $3.7B |
| MOH Molina Healthcare, Inc compare | $331.0M |
| PGNY Progyny, Inc. | $207.2M |
| CLOV Clover Health Investments, Corp. compare | $135.3M |
| ALHC Alignment Healthcare, Inc. compare | $108.0M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on PGNY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement